Clinical trial

Drug Therapy Induced Weight Loss to Improve Blood Vessel Function in Subjects With Obesity

NCT01351753

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Metformin Normalized identity: metforminView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Orlistat Normalized identity: orlistatView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Topiramate Normalized identity: topiramateView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Drug Therapy Induced Weight Loss to Improve Blood Vessel Function in Subjects With Obesity

Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2011-03-01

PhasePHASE2

Conditions

Obesityverified · MONDO: obesity disorder

Metabolic Syndrome Xverified · MONDO: metabolic syndrome X

Interventions

MetforminDRUG · verified · RxNorm: metformin

OrlistatDRUG · verified · RxNorm: orlistat

TopiramateDRUG · verified · RxNorm: topiramate

PlaceboDRUG

Sponsors & collaborators

University of Iowalead sponsor

Mapped research locations

Iowa CityIowa, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01351753 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.